What is ADMA Biologics's total revenue?

ADMA Biologics (ADMA) reported total revenue of $114.49M in Q1 2026.

How has ADMA Biologics's total revenue changed year-over-year?

ADMA Biologics's total revenue decreased by 0.3% year-over-year, from $114.8M to $114.49M.

What is the long-term trend for ADMA Biologics's total revenue?

Over 4 years (2021 to 2025), ADMA Biologics's total revenue has grown at a 58.4% compound annual growth rate (CAGR), from $80.94M to $510.17M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

ADMA Biologics ADMA Total Revenue

Total Revenue at other companies

AbCellera Biologics Inc.ABCL

$8.32M+96.3%

AnaptysBio, Inc.ANAB

$25.56M-8.0%

ZymeworksZYME

$2.41M-91.1%

Bio-Rad LaboratoriesBIO

$592.1M+1.1%

Quest DiagnosticsDGX

$2.9B+9.2%

AbbVieABBV

$15B+12.4%

Segments

By product

See full

ASCENIV$97.49M+27.7%

BIVIGAM$15.42M-54.0%

Intermediates And Other$833K-78.5%

By segment

See full

ADMA Bio Manufacturing$113.74M0.0%

Plasma Collection Centers$716K-31.8%

By geography

See full

US$137.38M+19.8%

Other financials

Income statement

See full

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

See full

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

See full

Operating cash flow$58.2M+396%

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

See full

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

See full

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

See full

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ADMA Biologics's total revenue?: ADMA Biologics (ADMA) reported total revenue of $114.49M in Q1 2026.
How has ADMA Biologics's total revenue changed year-over-year?: ADMA Biologics's total revenue decreased by 0.3% year-over-year, from $114.8M to $114.49M.
What is the long-term trend for ADMA Biologics's total revenue?: Over 4 years (2021 to 2025), ADMA Biologics's total revenue has grown at a 58.4% compound annual growth rate (CAGR), from $80.94M to $510.17M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.